Global Congestive Heart Failure (CHF) Treatment Devices
Global Congestive Heart Failure (CHF) Treatment Devices

Congestive Heart Failure (CHF) Treatment Devices Comprehensive Study by Type (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Other), Distribution Channel (Online, Offline), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Congestive Heart Failure (CHF) Treatment Devices Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 240 Pages 197 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Congestive Heart Failure (CHF) Treatment Devices Market Overview:
The modernized facilities reduced the physical activities, the stress level among the people are also rising and the Increasing prevalence of cardiovascular diseases, technological advancements, and an increasing number of cardiovascular surgeries. Thus, these factors are leading to cardiovascular conditions and are leading to rising demand for cardiovascular devices. Congestive heart failure is a condition or a collection of symptoms in which the heart isn't pumping enough blood to meet the body's needs. Heart failure usually develops slowly after an injury to the heart. alone. According to the research healthcare expenditures in the United States on heart failure are estimated to be around USD 39 billion per year, making it one of the largest expenses to the healthcare system. With the ageing of the population, Medtronic estimates that the number of patients with heart failure could exceed eight million by 2030.

Growth Drivers
  • The growing ageing population of both industrialized and developing nations
  • Growing incidence of obesity, diabetes, and hypertension

Market Trends
  • The incidences are rising due to the shift in the lifestyle and the other health conditions due to the change in the adoption of the modernized facilities

Roadblocks
  • High cost associated with the Congestive Heart Failure (CHF) Treatment Devices

Opportunities
  • Growth Opportunities in The Developing Nations
  • Heart failure prevalence is rising throughout the world

Challenges
  • Entrance of new players in the market


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Jarvik Heart (United States), ReliantHeart(United States), Biotronik SE & Co. (United States), Berlin Heart GmbH (Germany), St. Jude Medical Center(United States), Medtronic (Ireland), Boston Scientific Corporation(United States), Teleflex(United States), Sequena Medical (Switzerland) and Abiomed (United States). Additionally, following companies can also be profiled that are part of our coverage like CorWave (France), HeartWare(United States), CardioKinetix(United States), Alleviant Medical (United States) and CHF Solutions (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Congestive Heart Failure (CHF) Treatment Devices market by 2026. Considering Market by , the sub-segment i.e. will boost the Congestive Heart Failure (CHF) Treatment Devices market.

In November 2020 Vida Health Launches Virtual Congestive Heart Failure Management Program. Vida Health announced a new app-based, coach-centred virtual congestive heart failure (CHF) management program set to launch in December of this year. New app-based, coach-centred virtual congestive heart failure (CHF) management program set to launch in December of this year.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Congestive Heart Failure (CHF) Treatment Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Congestive Heart Failure (CHF) Treatment Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Congestive Heart Failure (CHF) Treatment Devices Manufacturer, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Ventricular Assist Devices
  • Counter Pulsation Devices
  • Implantable Cardioverter Defibrillators
  • Other
By Distribution Channel
  • Online
  • Offline

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The growing ageing population of both industrialized and developing nations
      • 3.2.2. Growing incidence of obesity, diabetes, and hypertension
    • 3.3. Market Challenges
      • 3.3.1. Entrance of new players in the market
    • 3.4. Market Trends
      • 3.4.1. The incidences are rising due to the shift in the lifestyle and the other health conditions due to the change in the adoption of the modernized facilities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Congestive Heart Failure (CHF) Treatment Devices, by Type, Distribution Channel, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Congestive Heart Failure (CHF) Treatment Devices (Value)
      • 5.2.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Value)
        • 5.2.1.1. Ventricular Assist Devices
        • 5.2.1.2. Counter Pulsation Devices
        • 5.2.1.3. Implantable Cardioverter Defibrillators
        • 5.2.1.4. Other
      • 5.2.2. Global Congestive Heart Failure (CHF) Treatment Devices by: Distribution Channel (Value)
        • 5.2.2.1. Online
        • 5.2.2.2. Offline
      • 5.2.3. Global Congestive Heart Failure (CHF) Treatment Devices by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Congestive Heart Failure (CHF) Treatment Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Congestive Heart Failure (CHF) Treatment Devices (Volume)
      • 5.3.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Volume)
        • 5.3.1.1. Ventricular Assist Devices
        • 5.3.1.2. Counter Pulsation Devices
        • 5.3.1.3. Implantable Cardioverter Defibrillators
        • 5.3.1.4. Other
      • 5.3.2. Global Congestive Heart Failure (CHF) Treatment Devices by: Distribution Channel (Volume)
        • 5.3.2.1. Online
        • 5.3.2.2. Offline
      • 5.3.3. Global Congestive Heart Failure (CHF) Treatment Devices by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Global Congestive Heart Failure (CHF) Treatment Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Congestive Heart Failure (CHF) Treatment Devices (Price)
      • 5.4.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Price)
  • 6. Congestive Heart Failure (CHF) Treatment Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Jarvik Heart (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ReliantHeart(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biotronik SE & Co. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Berlin Heart GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. St. Jude Medical Center(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teleflex(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sequena Medical (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abiomed (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Congestive Heart Failure (CHF) Treatment Devices Sale, by Type, Distribution Channel, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Congestive Heart Failure (CHF) Treatment Devices (Value)
      • 7.2.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Value)
        • 7.2.1.1. Ventricular Assist Devices
        • 7.2.1.2. Counter Pulsation Devices
        • 7.2.1.3. Implantable Cardioverter Defibrillators
        • 7.2.1.4. Other
      • 7.2.2. Global Congestive Heart Failure (CHF) Treatment Devices by: Distribution Channel (Value)
        • 7.2.2.1. Online
        • 7.2.2.2. Offline
      • 7.2.3. Global Congestive Heart Failure (CHF) Treatment Devices by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Congestive Heart Failure (CHF) Treatment Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Congestive Heart Failure (CHF) Treatment Devices (Volume)
      • 7.3.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Volume)
        • 7.3.1.1. Ventricular Assist Devices
        • 7.3.1.2. Counter Pulsation Devices
        • 7.3.1.3. Implantable Cardioverter Defibrillators
        • 7.3.1.4. Other
      • 7.3.2. Global Congestive Heart Failure (CHF) Treatment Devices by: Distribution Channel (Volume)
        • 7.3.2.1. Online
        • 7.3.2.2. Offline
      • 7.3.3. Global Congestive Heart Failure (CHF) Treatment Devices by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Global Congestive Heart Failure (CHF) Treatment Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Congestive Heart Failure (CHF) Treatment Devices (Price)
      • 7.4.1. Global Congestive Heart Failure (CHF) Treatment Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Congestive Heart Failure (CHF) Treatment Devices: by Type(USD Million)
  • Table 2. Congestive Heart Failure (CHF) Treatment Devices Ventricular Assist Devices , by Region USD Million (2015-2020)
  • Table 3. Congestive Heart Failure (CHF) Treatment Devices Counter Pulsation Devices , by Region USD Million (2015-2020)
  • Table 4. Congestive Heart Failure (CHF) Treatment Devices Implantable Cardioverter Defibrillators , by Region USD Million (2015-2020)
  • Table 5. Congestive Heart Failure (CHF) Treatment Devices Other , by Region USD Million (2015-2020)
  • Table 6. Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel(USD Million)
  • Table 7. Congestive Heart Failure (CHF) Treatment Devices Online , by Region USD Million (2015-2020)
  • Table 8. Congestive Heart Failure (CHF) Treatment Devices Offline , by Region USD Million (2015-2020)
  • Table 9. Congestive Heart Failure (CHF) Treatment Devices: by End User(USD Million)
  • Table 10. Congestive Heart Failure (CHF) Treatment Devices Hospitals , by Region USD Million (2015-2020)
  • Table 11. Congestive Heart Failure (CHF) Treatment Devices Clinics , by Region USD Million (2015-2020)
  • Table 12. Congestive Heart Failure (CHF) Treatment Devices Others , by Region USD Million (2015-2020)
  • Table 13. South America Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2015-2020)
  • Table 14. South America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 15. South America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 16. South America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 17. Brazil Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 18. Brazil Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 19. Brazil Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 20. Argentina Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 21. Argentina Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 22. Argentina Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 23. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 25. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 26. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 29. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 30. China Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 31. China Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 32. China Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 33. Japan Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 34. Japan Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 35. Japan Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 36. India Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 37. India Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 38. India Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 39. South Korea Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 40. South Korea Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 41. South Korea Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 42. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 43. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 44. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 45. Australia Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 46. Australia Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 47. Australia Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 51. Europe Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2015-2020)
  • Table 52. Europe Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 53. Europe Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 54. Europe Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 55. Germany Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 56. Germany Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 57. Germany Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 58. France Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 59. France Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 60. France Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 61. Italy Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 62. Italy Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 63. Italy Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 64. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 66. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 67. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 68. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 69. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 70. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 73. MEA Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2015-2020)
  • Table 74. MEA Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 75. MEA Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 76. MEA Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 77. Middle East Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 78. Middle East Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 79. Middle East Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 80. Africa Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 81. Africa Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 82. Africa Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 83. North America Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2015-2020)
  • Table 84. North America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 85. North America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 86. North America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 87. United States Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 88. United States Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 89. United States Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 90. Canada Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 91. Canada Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 92. Canada Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 93. Mexico Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2015-2020)
  • Table 94. Mexico Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2015-2020)
  • Table 95. Mexico Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2015-2020)
  • Table 96. Congestive Heart Failure (CHF) Treatment Devices Sales: by Type(K Units)
  • Table 97. Congestive Heart Failure (CHF) Treatment Devices Sales Ventricular Assist Devices , by Region K Units (2015-2020)
  • Table 98. Congestive Heart Failure (CHF) Treatment Devices Sales Counter Pulsation Devices , by Region K Units (2015-2020)
  • Table 99. Congestive Heart Failure (CHF) Treatment Devices Sales Implantable Cardioverter Defibrillators , by Region K Units (2015-2020)
  • Table 100. Congestive Heart Failure (CHF) Treatment Devices Sales Other , by Region K Units (2015-2020)
  • Table 101. Congestive Heart Failure (CHF) Treatment Devices Sales: by Distribution Channel(K Units)
  • Table 102. Congestive Heart Failure (CHF) Treatment Devices Sales Online , by Region K Units (2015-2020)
  • Table 103. Congestive Heart Failure (CHF) Treatment Devices Sales Offline , by Region K Units (2015-2020)
  • Table 104. Congestive Heart Failure (CHF) Treatment Devices Sales: by End User(K Units)
  • Table 105. Congestive Heart Failure (CHF) Treatment Devices Sales Hospitals , by Region K Units (2015-2020)
  • Table 106. Congestive Heart Failure (CHF) Treatment Devices Sales Clinics , by Region K Units (2015-2020)
  • Table 107. Congestive Heart Failure (CHF) Treatment Devices Sales Others , by Region K Units (2015-2020)
  • Table 108. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2015-2020)
  • Table 109. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 110. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 111. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 112. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 113. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 114. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 115. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 116. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 117. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 118. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 119. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 120. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 121. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2015-2020)
  • Table 122. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 123. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 124. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 125. China Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 126. China Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 127. China Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 128. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 129. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 130. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 131. India Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 132. India Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 133. India Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 134. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 135. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 136. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 137. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 138. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 139. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 140. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 141. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 142. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 144. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 146. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2015-2020)
  • Table 147. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 148. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 149. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 150. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 151. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 152. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 153. France Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 154. France Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 155. France Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 156. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 157. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 158. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 159. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 160. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 161. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 162. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 163. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 164. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 165. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 166. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 167. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 168. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2015-2020)
  • Table 169. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 170. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 171. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 172. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 173. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 174. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 175. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 176. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 177. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 178. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2015-2020)
  • Table 179. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 180. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 181. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 182. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 183. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 184. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 185. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 186. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 187. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 188. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2015-2020)
  • Table 189. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2015-2020)
  • Table 190. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2015-2020)
  • Table 191. Congestive Heart Failure (CHF) Treatment Devices: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Congestive Heart Failure (CHF) Treatment Devices: by Type(USD Million)
  • Table 203. Congestive Heart Failure (CHF) Treatment Devices Ventricular Assist Devices , by Region USD Million (2021-2026)
  • Table 204. Congestive Heart Failure (CHF) Treatment Devices Counter Pulsation Devices , by Region USD Million (2021-2026)
  • Table 205. Congestive Heart Failure (CHF) Treatment Devices Implantable Cardioverter Defibrillators , by Region USD Million (2021-2026)
  • Table 206. Congestive Heart Failure (CHF) Treatment Devices Other , by Region USD Million (2021-2026)
  • Table 207. Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel(USD Million)
  • Table 208. Congestive Heart Failure (CHF) Treatment Devices Online , by Region USD Million (2021-2026)
  • Table 209. Congestive Heart Failure (CHF) Treatment Devices Offline , by Region USD Million (2021-2026)
  • Table 210. Congestive Heart Failure (CHF) Treatment Devices: by End User(USD Million)
  • Table 211. Congestive Heart Failure (CHF) Treatment Devices Hospitals , by Region USD Million (2021-2026)
  • Table 212. Congestive Heart Failure (CHF) Treatment Devices Clinics , by Region USD Million (2021-2026)
  • Table 213. Congestive Heart Failure (CHF) Treatment Devices Others , by Region USD Million (2021-2026)
  • Table 214. South America Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2021-2026)
  • Table 215. South America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 216. South America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 217. South America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 218. Brazil Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 219. Brazil Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 220. Brazil Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 221. Argentina Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 222. Argentina Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 223. Argentina Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 224. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 225. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 226. Rest of South America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 227. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2021-2026)
  • Table 228. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 229. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 230. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 231. China Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 232. China Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 233. China Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 234. Japan Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 235. Japan Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 236. Japan Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 237. India Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 238. India Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 239. India Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 240. South Korea Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 241. South Korea Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 242. South Korea Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 243. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 244. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 245. Taiwan Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 246. Australia Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 247. Australia Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 248. Australia Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 250. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 252. Europe Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2021-2026)
  • Table 253. Europe Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 254. Europe Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 255. Europe Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 256. Germany Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 257. Germany Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 258. Germany Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 259. France Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 260. France Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 261. France Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 262. Italy Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 263. Italy Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 264. Italy Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 265. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 266. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 267. United Kingdom Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 268. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 269. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 270. Netherlands Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 271. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 272. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 273. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 274. MEA Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2021-2026)
  • Table 275. MEA Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 276. MEA Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 277. MEA Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 278. Middle East Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 279. Middle East Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 280. Middle East Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 281. Africa Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 282. Africa Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 283. Africa Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 284. North America Congestive Heart Failure (CHF) Treatment Devices, by Country USD Million (2021-2026)
  • Table 285. North America Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 286. North America Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 287. North America Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 288. United States Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 289. United States Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 290. United States Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 291. Canada Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 292. Canada Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 293. Canada Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 294. Mexico Congestive Heart Failure (CHF) Treatment Devices, by Type USD Million (2021-2026)
  • Table 295. Mexico Congestive Heart Failure (CHF) Treatment Devices, by Distribution Channel USD Million (2021-2026)
  • Table 296. Mexico Congestive Heart Failure (CHF) Treatment Devices, by End User USD Million (2021-2026)
  • Table 297. Congestive Heart Failure (CHF) Treatment Devices Sales: by Type(K Units)
  • Table 298. Congestive Heart Failure (CHF) Treatment Devices Sales Ventricular Assist Devices , by Region K Units (2021-2026)
  • Table 299. Congestive Heart Failure (CHF) Treatment Devices Sales Counter Pulsation Devices , by Region K Units (2021-2026)
  • Table 300. Congestive Heart Failure (CHF) Treatment Devices Sales Implantable Cardioverter Defibrillators , by Region K Units (2021-2026)
  • Table 301. Congestive Heart Failure (CHF) Treatment Devices Sales Other , by Region K Units (2021-2026)
  • Table 302. Congestive Heart Failure (CHF) Treatment Devices Sales: by Distribution Channel(K Units)
  • Table 303. Congestive Heart Failure (CHF) Treatment Devices Sales Online , by Region K Units (2021-2026)
  • Table 304. Congestive Heart Failure (CHF) Treatment Devices Sales Offline , by Region K Units (2021-2026)
  • Table 305. Congestive Heart Failure (CHF) Treatment Devices Sales: by End User(K Units)
  • Table 306. Congestive Heart Failure (CHF) Treatment Devices Sales Hospitals , by Region K Units (2021-2026)
  • Table 307. Congestive Heart Failure (CHF) Treatment Devices Sales Clinics , by Region K Units (2021-2026)
  • Table 308. Congestive Heart Failure (CHF) Treatment Devices Sales Others , by Region K Units (2021-2026)
  • Table 309. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2021-2026)
  • Table 310. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 311. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 312. South America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 313. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 314. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 315. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 316. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 317. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 318. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 319. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 320. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 321. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 322. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2021-2026)
  • Table 323. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 324. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 325. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 326. China Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 327. China Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 328. China Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 329. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 330. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 331. Japan Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 332. India Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 333. India Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 334. India Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 335. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 336. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 337. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 338. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 339. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 340. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 341. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 342. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 343. Australia Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 344. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 345. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 346. Rest of Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 347. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2021-2026)
  • Table 348. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 349. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 350. Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 351. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 352. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 353. Germany Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 354. France Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 355. France Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 356. France Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 357. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 358. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 359. Italy Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 360. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 361. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 362. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 363. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 364. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 365. Netherlands Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 366. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 367. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 368. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 369. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2021-2026)
  • Table 370. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 371. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 372. MEA Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 373. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 374. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 375. Middle East Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 376. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 377. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 378. Africa Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 379. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Country K Units (2021-2026)
  • Table 380. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 381. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 382. North America Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 383. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 384. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 385. United States Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 386. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 387. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 388. Canada Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 389. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by Type K Units (2021-2026)
  • Table 390. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by Distribution Channel K Units (2021-2026)
  • Table 391. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales, by End User K Units (2021-2026)
  • Table 392. Congestive Heart Failure (CHF) Treatment Devices: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices: by End User USD Million (2015-2020)
  • Figure 7. South America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 8. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 9. Europe Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 10. MEA Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 11. North America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices: by Type K Units (2015-2020)
  • Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel K Units (2015-2020)
  • Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices: by End User K Units (2015-2020)
  • Figure 15. South America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 16. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 17. Europe Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 18. MEA Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 19. North America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices: by Type USD/Units (2015-2020)
  • Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices share by Players 2020 (%)
  • Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices share by Players (Top 3) 2020(%)
  • Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Jarvik Heart (United States) Revenue, Net Income and Gross profit
  • Figure 26. Jarvik Heart (United States) Revenue: by Geography 2020
  • Figure 27. ReliantHeart(United States) Revenue, Net Income and Gross profit
  • Figure 28. ReliantHeart(United States) Revenue: by Geography 2020
  • Figure 29. Biotronik SE & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Biotronik SE & Co. (United States) Revenue: by Geography 2020
  • Figure 31. Berlin Heart GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Berlin Heart GmbH (Germany) Revenue: by Geography 2020
  • Figure 33. St. Jude Medical Center(United States) Revenue, Net Income and Gross profit
  • Figure 34. St. Jude Medical Center(United States) Revenue: by Geography 2020
  • Figure 35. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 37. Boston Scientific Corporation(United States) Revenue, Net Income and Gross profit
  • Figure 38. Boston Scientific Corporation(United States) Revenue: by Geography 2020
  • Figure 39. Teleflex(United States) Revenue, Net Income and Gross profit
  • Figure 40. Teleflex(United States) Revenue: by Geography 2020
  • Figure 41. Sequena Medical (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Sequena Medical (Switzerland) Revenue: by Geography 2020
  • Figure 43. Abiomed (United States) Revenue, Net Income and Gross profit
  • Figure 44. Abiomed (United States) Revenue: by Geography 2020
  • Figure 45. Global Congestive Heart Failure (CHF) Treatment Devices: by Type USD Million (2021-2026)
  • Figure 46. Global Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel USD Million (2021-2026)
  • Figure 47. Global Congestive Heart Failure (CHF) Treatment Devices: by End User USD Million (2021-2026)
  • Figure 48. South America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 49. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 50. Europe Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 51. MEA Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 52. North America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 53. Global Congestive Heart Failure (CHF) Treatment Devices: by Type K Units (2021-2026)
  • Figure 54. Global Congestive Heart Failure (CHF) Treatment Devices: by Distribution Channel K Units (2021-2026)
  • Figure 55. Global Congestive Heart Failure (CHF) Treatment Devices: by End User K Units (2021-2026)
  • Figure 56. South America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 57. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 58. Europe Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 59. MEA Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 60. North America Congestive Heart Failure (CHF) Treatment Devices Share (%), by Country
  • Figure 61. Global Congestive Heart Failure (CHF) Treatment Devices: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Jarvik Heart (United States)
  • ReliantHeart(United States)
  • Biotronik SE & Co. (United States)
  • Berlin Heart GmbH (Germany)
  • St. Jude Medical Center(United States)
  • Medtronic (Ireland)
  • Boston Scientific Corporation(United States)
  • Teleflex(United States)
  • Sequena Medical (Switzerland)
  • Abiomed (United States)
Additional players considered in the study are as follows:
CorWave (France) , HeartWare(United States) , CardioKinetix(United States) , Alleviant Medical (United States) , CHF Solutions (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation